Scientific News

Evangelina López (left) and Núria Malats. / Christian Esposito. Madmoviex. CNIO

Basic Research
12.01.2026 Nature Communications. A CNIO study identifies new genes that predispose an individual to pancreatic cancer A new study by the National Cancer Research Centre (CNIO) has identified several sets of genes...

Translational
07.01.2026 Leading group in brain metastasis research predicts mid-term advances that will improve patients’ lives In his conferences, Manuel Valiente asks the audience which results from his laboratory at the...

Basic Research
15.12.2025 Science Advances. The way our cells respond to oestrogen, the main female sex hormone, depends on how DNA is ‘supercoiled’ Oestrogens, the main female sex hormone, although they also perform some functions in men, are...

Elena Zamorano, researcher in the Experimental Oncology Group at the CNIO. /Christian Esposito. CNIO

Translational
21.10.2025 PNAS. New drug in trial for the main oncogene in pancreatic cancer: one small step for patients, one giant leap for research Pancreatic cancer poses biomedical challenges so complex that even advancements that represent...

From the left: Paula Martínez, Raúl Sánchez-Vázquez and Maria A. Blasco. / CNIO

Basic Research
18.09.2025 Genes and Development. New findings explain how a mutation in a cancer-related gen causes pulmonary fibrosis Idiopathic pulmonary fibrosis is a potentially fatal disease currently without treatment, in which...

Núria Malats, Nannan Xue and Sergio Sabroso-Lasa, at the Spanish National Cancer Research Centre (CNIO). / Pilar Gil. CNIO

Translational
16.09.2025 GUT. An algorithm that predicts whether pancreatic cancer has spread to other organs could help avoid unnecessary surgeries Pancreatic cancer remains one of the biggest challenges in the field of oncology. Numbers of cases...

Gonçalo Bernardes. / Laura M. Lombardía. CNIO

Translational
31.07.2025 Nature Communications. CNIO researcher develops a test aimed to detect early-stage tumors with a blood sample Current methods for cancer diagnosis are based on identifying biomarkers – molecules that...

CNIO researcher Marisol Soengas (left) and Marisol Quintero, CEO of Highlight Therapeutics, at the entrance of the National Cancer Research Centre (CNIO). /Scienseed

Translational
15.07.2025 New clinical trial targets the most common form of skin cancer with a compound based on CNIO discoveries Around 15 years ago, in 2009, the team led by Marisol Soengas at the Spanish National Cancer...

Mercedes Robledo, Sara Mellid and Alberto Cascón, at the Spanish National Cancer Research Centre (CNIO). /Laura M. Lombardía. CNIO

Translational
10.07.2025 Genes and Disease. A pioneering study reveals new genetic mechanisms involved in rare head and neck tumours Paragangliomas and pheochromocytomas are rare neuroendocrine tumors, occurring in only 3 to 8 cases...